N-Phenethylaminopropiophenones as lipogenesis inhibitors

A method of inhibiting lipogenesis in a mammal, which comprises administering, to a mammal in need of such treatment, orally or parenterally a lipogenesis inhibiting amount of a compound of the formula ##STR2## wherein R is hydrogen or hydroxyl;

• R.sup.1 is hydrogen or methyl;
• R.sup.2 is hydrogen or methyl;
• n is zero, one or two;
• X is hydroxyl, with the proviso that when n is one, the hydroxyl moiety is bonded to the carbon atom at the 4-position in the phenyl ring, and when n is two, the hydroxyl moieties are bonded to the carbon atoms in the 3- and 4-positions of the phenyl ring, and their pharmacologically acceptable acid addition salts.